Ondansetron is effective in treatment of pruritus after intrathecal fentanyl [6]

Regional Anesthesia and Pain Medicine

Volumn 27, Issue 5, 2002, Pages 538-540

  Henry, Ashraf ^a   Tetzlaff, John E ^a   Steckner, Karen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; DIPHENHYDRAMINE; FENTANYL; MIDAZOLAM; NALOXONE; ONDANSETRON;

ADULT; CASE REPORT; DISEASE COURSE; DISEASE RESISTANCE; DRUG EFFICACY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; TREATMENT OUTCOME; URINE RETENTION;

EID: 0036746833     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/00115550-200209000-00028     Document Type: Letter

References (10)

1. Kuraishi Y, Yamaguchi T, Miyamoto T. Itch-scratch responses induced by opioids through central mu opioid receptors in mice. J Biomed Sci 2000;7:248-252.
2. Yamaguchi T, Nagasawa T, Satoh M. Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice. Neurosci Res 1999;35:77-83.
3. Schworer H, Hartmann H, Ramadori G. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: Effectiveness of ondansetron. Pain 1995;61:33-37.
4. Muller C, Pongratz S, Pidlich J. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: A randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998;10:865-870.
5. Balaskas EV, Bamihas GI, Karamouzis M. Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients. Nephron 1998;78:395-402.
6. Miller R. Anesthesia (ed 5). Philadelphia, PA: Churchill Livingston; 2000:293.
7. Borgeat A, Stirnemann HR. Ondansetron is effective to treat spinal or epidural morphine-induced pruritus. Anesthesiology 1999;90:432-436.
8. Arai L, Stayer S, Schwartz R, Dorsey A. The use of ondansetron to treat pruritus associated with intrathecal morphine in two pediatric patients. Pediatr Anesth 1996;6:337-339.
9. Kyriakides K, Hussain SK, Hobbs GJ. Management of opioid-induced pruritus: A role for 5-HT3 antagonists. Br J Anaesth 1999;82:439-441.
10. Hamel E. The biology of serotonin receptors: Focus on migraine pathophysiology and treatment. Can J Neurol Sci 1999;26:S2-6.